Federico Asch
Overview
Explore the profile of Federico Asch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
227
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Singh G, Price M, Shuvy M, Rogers J, Grasso C, Bedogni F, et al.
JACC Cardiovasc Interv
. 2024 Oct;
17(21):2530-2540.
PMID: 39453373
Background: Reducing mitral regurgitation (MR) during mitral transcatheter edge-to-edge repair (M-TEER) may come at the cost of increased mitral valve gradient (MVG). The combined impact of residual MR and MVG...
2.
Sultan I, Reardon M, Sondergaard L, Chehab B, Smith D, Walton A, et al.
Struct Heart
. 2024 Aug;
8(4):100293.
PMID: 39100579
Background: The Navitor Investigational Device Exemption (IDE) study is a prospective, multicenter, global study assessing the safety and effectiveness of the Navitor valve in a population with severe, symptomatic aortic...
3.
Rogers J, Asch F, Sorajja P, Mahoney P, Price M, Maisano F, et al.
JACC Cardiovasc Interv
. 2023 Jun;
16(12):1474-1485.
PMID: 37380229
Background: Anatomical and clinical criteria to define mitral transcatheter edge-to-edge repair (TEER) "unsuitability" have been proposed on the basis of a Heart Valve Collaboratory consensus opinion from physician experience with...
4.
Peck D, Beaton A, Nunes M, Ollberding N, Hays A, Hiremath P, et al.
Echocardiography
. 2023 Apr;
40(5):388-396.
PMID: 37062026
Introduction: Cardiac involvement seems to impact prognosis of COVID-19, especially in critically ill patients. We aimed to assess the prognostic value of right ventricular (RV) and left ventricular (LV) dysfunction,...
5.
Shuvy M, von Bardeleben R, Grasso C, Raake P, Lurz P, Zamorano J, et al.
ESC Heart Fail
. 2023 Jan;
10(2):1122-1132.
PMID: 36599332
Aim: Patients with severe mitral regurgitation (MR) and acute heart failure (HF) have refractory symptoms without adequate response to medical therapy. The objective of this analysis was to assess the...
6.
Levy M, Waters A, Sen S, Castel A, Plankey M, Molock S, et al.
PLoS One
. 2021 Dec;
16(12):e0261746.
PMID: 34941922
Objective: Women living with HIV (WLWH) experience psychosocial stress related to social-structural vulnerabilities. To investigate neuroendocrine pathways linking stress and increased cardiovascular disease risk among WLWH, we evaluated associations between...
7.
Waksman R, Torguson R, Medranda G, Shea C, Zhang C, Gordon P, et al.
Am Heart J
. 2021 Mar;
237:25-33.
PMID: 33713618
Background: Previous studies from the Low Risk TAVR (LRT) trial demonstrated that transcatheter aortic valve replacement (TAVR) is safe and feasible in low-risk patients, with excellent 30-day and 1-year outcomes....
8.
Khoury K, Lynce F, Barac A, Geng X, Dang C, Yu A, et al.
Breast Cancer Res Treat
. 2021 Jan;
185(3):863-868.
PMID: 33400034
Purpose: HER2-targeted therapies are associated with cardiotoxicity which is usually asymptomatic and reversible. We report the updated cardiac safety assessment of patients with compromised heart function receiving HER2-targeted therapy for...
9.
Hahn R, Asch F, Weissman N, Grayburn P, Kar S, Lim S, et al.
J Am Coll Cardiol
. 2020 Sep;
76(11):1305-1314.
PMID: 32912445
Background: The presence of tricuspid regurgitation (TR) may affect prognosis in patients with mitral regurgitation (MR). Objectives: This study sought to determine the impact of TR on outcomes in patients...
10.
Rogers T, Greenspun B, Weissman G, Torguson R, Craig P, Shults C, et al.
JACC Cardiovasc Interv
. 2020 Mar;
13(6):726-735.
PMID: 32192693
Objectives: The aim of this study was to evaluate the feasibility of coronary access and aortic valve reintervention in low-risk patients undergoing transcatheter aortic valve replacement (TAVR) with a balloon-expandable...